Ura Nobuyuki, Shinshi Yasuyuki
Second Department of Internal Medicine, Sapporo Medical University School of Medicine.
Nihon Rinsho. 2004 Jan;62(1):57-64.
Insulin resistance and compensatory hyperinsulinemia are recognized not only in type 2 diabetes mellitus(DM) but also in essential hypertension(EHT), hyperlipidemia and obesity; these are known as the components of metabolic syndrome and accumulation of these components increase risk of cardiovascular diseases(CVD). When coronary angiographic findings were evaluated in patients with coronary artery disease(CAD), the severity was higher in CAD with DM than that without DM. Even in CAD without DM, the severity of coronary angiographic findings was higher in CAD with insulin resistance than that without insulin resistance. When residents of rural communities in Japan were followed 8 years, the incidence of CVD was 3.5 times higher in subjects with insulin resistance than those without insulin resistance. One of the intracellular signal transduction of insulin receptor; MAP kinase may be concerned atherosclerotic mechanisms of insulin resistance. These findings suggest that insulin resistance is a significant background of atherosclerosis, and insulin resistance is one of the major facilitation factors of genesis and progression of CVD.
胰岛素抵抗和代偿性高胰岛素血症不仅在2型糖尿病(DM)中被认识到,在原发性高血压(EHT)、高脂血症和肥胖症中也存在;这些被称为代谢综合征的组成部分,这些组成部分的积累会增加心血管疾病(CVD)的风险。当对冠心病(CAD)患者的冠状动脉造影结果进行评估时,合并DM的CAD患者的严重程度高于未合并DM的患者。即使在未合并DM的CAD患者中,合并胰岛素抵抗的CAD患者的冠状动脉造影结果严重程度也高于未合并胰岛素抵抗的患者。对日本农村社区居民进行8年随访时,有胰岛素抵抗的受试者的CVD发病率是无胰岛素抵抗受试者的3.5倍。胰岛素受体的细胞内信号转导之一;丝裂原活化蛋白激酶可能与胰岛素抵抗的动脉粥样硬化机制有关。这些发现表明胰岛素抵抗是动脉粥样硬化的重要背景,胰岛素抵抗是CVD发生和发展的主要促进因素之一。